Table 5.
Ability of t-BOOH to promote dissociation of σE-ChrR complexes containing wild type or variant ChrR proteins in vivo1.
ChrR Protein |
Before t-BOOH |
After t-BOOH |
Fold Change |
---|---|---|---|
WT | 19 ± 3 | 173 ± 64 | 9.1 |
ChrR85 | 34 ± 6 | 45 ± 7 | 1.3 |
H141A | 25 ± 2 | 44 ± 9 | 1.7 |
H143A | 31 ± 4 | 38 ± 2 | 1.2 |
E147A | 20 ± 4 | 25 ± 6 | 1.3 |
H177A | 40 ± 8 | 50 ± 9 | 1.3 |
C187A | 44 ± 6 | 82 ± 14 | 1.9 |
C189A | 27 ± 8 | 64 ± 12 | 2.4 |
C187S | 109 ± 26 | 256 ± 75 | 2.3 |
C189S | 60 ± 9 | 262 ± 83 | 4.4 |
Shown are the differential rates of β-galactosidase synthesis measured from an rpoE∷lacZ operon fusion that requires σE in cells containing the indicated ChrR protein as their sole source of this anti-σ factor before or after addition of 100 µM t-BOOH. The column labeled fold change reports the ratio of these rates before and after addition of 100 µM t-BOOH.